CellaVision ABCVLLY +12.06%69 Dividend Yield % is 2.11% as of Jun. 24, 2026, which is 127% above its 10-year median of 0.93. GuruFocus rates CVLLY with a GF Score™ of 69/100 and a GF Value™ of $12.48 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 327 Medical Devices & Instruments companies, CellaVision AB ranks better than 51.68% on this metric.
As of today (2026-06-24), the Trailing Annual Dividend Yield of CellaVision AB is 2.11%.
Good Sign:
CellaVision AB stock Dividend Yield % is close to 5-year high.
The historical rank and industry rank for CellaVision AB's Dividend Yield % or its related term are showing as below:
CVLLY'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.16 Med: 0.93 Max: 2.52
Current: 2.11
During the past 13 years, the highest Dividend Yield of CellaVision AB was 2.52%. The lowest was 0.16%. And the median was 0.93%.
CVLLY's Dividend Yield % is ranked better than 51.68% of 327
companies
in the Medical Devices & Instruments industry
Industry Median: 1.98
vs CVLLY: 2.11
During the past 12 months, CellaVision AB's average Dividends Per Share Growth Rate was 11.10% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 7.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of CellaVision AB was 55.40% per year. The lowest was -20.60% per year. And the median was 14.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
CellaVision AB (OTCPK:CVLLY) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for CellaVision AB's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVLLY vs ABT, SYK, MDT: Dividend Yield % Comparison
For the Medical Devices subindustry, CellaVision AB's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CellaVision AB Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where CellaVision AB's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
CellaVision AB Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.148749
2026-04-30
2026-04-30
2026-05-20
Cash Dividend
annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
CellaVision AB's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.148749
/
7.06
=
2.11 %
Current Share Price is $7.06. CellaVision AB's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.148749.
CellaVision AB's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.148749
/
7.06
=
2.11 %
Current Share Price is $7.06. CellaVision AB's Dividends per Share for the forward twelve months is calculated as $0.148749 * 1 = $0.148749.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CellaVision AB (CVLLY) has a Dividend Yield % of 2.11% as of Jun. 24, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on CellaVision AB and its competitors. This is 127% above median its historical median of 0.93. Over the past decade, CellaVision AB's Dividend Yield % has ranged from 0.16 to 2.52. According to the industry distribution chart, CellaVision AB ranks #158 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 48.3%.
Is CellaVision AB's Dividend Yield % too high?
CellaVision AB's current Dividend Yield % of 2.11% is 127% above median its 10-year median of 0.93. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 2.52. The Medical Devices & Instruments industry median Dividend Yield % is 1.98. CellaVision AB's value of 2.11% is 6.6% above this industry median. Based on the distribution chart, CellaVision AB ranks #158 out of 327 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, CellaVision AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellaVision AB's Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CellaVision AB ranks #158 out of 327 companies for Dividend Yield %. This puts CellaVision AB in the upper half of its industry. The industry median Dividend Yield % is 1.98. CellaVision AB's value of 2.11% is 6.6% above this benchmark. Historically, CellaVision AB's own Dividend Yield % has ranged from 0.16 to 2.52 over the past decade. While the company's 10-year median is 0.93 vs. the industry median of 1.98, CellaVision AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.98, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CellaVision AB's current Dividend Yield % of 2.11% is 6.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on CellaVision AB and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CellaVision AB's current Dividend Yield % is 2.11%, which is 127% above median its own 10-year median of 0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellaVision AB stock overvalued right now?
Based on GuruFocus' analysis, CellaVision AB (CVLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.48, compared to a current price of $7.06 — trading 43.4% below its estimated fair value. The current Dividend Yield % is 2.11%, which is 127% above median its 10-year median of 0.93 and 6.6% above the Medical Devices & Instruments industry median of 1.98. CellaVision AB's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For CellaVision AB (CVLLY), the current Dividend Yield % is 2.11% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CellaVision AB (CVLLY) Overvalued in 2026?
Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued.
The current stock price of $7.06 is trading 43.4% below its estimated GF Value™ of $12.48.
GuruFocus considers CellaVision AB to be Significantly Undervalued.
Key valuation signals for CVLLY:
Dividend Yield %: 2.11% (127% above median its 10-year median of 0.93)
GF Value™: $12.48 vs. price of $7.06 (43.4% below fair value)
Industry Position: 6.6% above the Medical Devices & Instruments median (#158 of 327)
No single metric tells the full story. See the CVLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
69GF Score
Get the complete analysis for CVLLY
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVLLY has been successfully added to your 
